Retrospective evaluation of the symptom-based work restriction strategy of healthcare providers in the first epidemic of COVID-19 at a tertiary care hospital in Tokyo, Japan.

Autor: Shikano H; Department of Clinical Laboratory, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan., Uehara Y; Department of Clinical Laboratory, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan; Department of Infectious Diseases, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan; Department of Microbiology, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan. Electronic address: yukiue@luke.ac.jp., Kuboki R; Department of Clinical Laboratory, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan., Tashino E; Department of Clinical Laboratory, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan., Nakahara F; Department of Clinical Laboratory, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan., Matsumoto Y; Department of Clinical Laboratory, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan., Kusakabe S; Department of Clinical Laboratory, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan., Fukazawa C; Department of Clinical Laboratory, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan., Matsuo T; Department of Infectious Diseases, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan., Mori N; Department of Infectious Diseases, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan., Ayabe A; Division of Health Care Administration, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan., Jinta T; Division of Health Care Administration, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan; Department of Respiratory Medicine, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan., Taki F; Division of Health Care Administration, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan; Department of Nephrology, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan., Sakamoto F; Quality Improvement Center, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan., Takahashi O; Graduate School of Public Health, St. Luke's International University, Chuo-ku, Tokyo, Japan; Department of General Internal Medicine, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan., Fukui T; Graduate School of Public Health, St. Luke's International University, Chuo-ku, Tokyo, Japan; Department of General Internal Medicine, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan.
Jazyk: angličtina
Zdroj: American journal of infection control [Am J Infect Control] 2022 Jun; Vol. 50 (6), pp. 645-650. Date of Electronic Publication: 2021 Dec 08.
DOI: 10.1016/j.ajic.2021.11.029
Abstrakt: Background: Effectiveness of restricting healthcare providers (HCPs) from working based on the coronavirus disease 2019 (COVID-19)-like symptoms should be evaluated.
Methods: A total of 495 HCPs in a tertiary care hospital in Tokyo, Japan, participated in this study between June and July in 2020. Analysis of serum anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody to identify infected HCPs, questionnaire surveys, and medical record reviews were conducted to evaluate the appropriateness of symptom-based work restriction for 10 days.
Results: Five participants (1.0%) were identified as infected. Forty-six participants (9.3%) experienced work restriction and all 5 infected participants (10.8%) restricted working, even though the real-time reverse transcription-polymerase chain reaction was positive only in 4 participants (80.0%). There were no unexpectedly infected participants among those who did not experience work restriction. However, only 46 of 110 HCPs with COVID-19-like symptoms (41.8%) restricted themselves from working.
Discussion: Symptom-based work restriction strategy successfully prevented infected HCPs to work, but showed low specificity to identify truly infected HCPs, and their low adherence to the strategy was revealed.
Conclusions: HCPs with COVID-19-like symptoms should restrict working as the first step of infection prevention, but the strategy to identify truly infected HCPs is necessary.
(Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: